{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    11,
    12,
    13,
    14,
    16,
    17,
    18,
    19,
    22,
    23,
    24,
    25,
    26,
    27,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Avelumab",
        "type": {
          "id": "fd612f9a-466d-48e0-8899-0d3881454220",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "8c3bec62-34a3-4f92-be09-cf45892afebd",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Fully human monoclonal antibody (mAb) of the immunoglobulin (Ig) G1 isotype that selectively binds to PD-L1.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Axitinib",
        "type": {
          "id": "545aa9ec-307e-4767-a5c0-c25b6836932b",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "1782ab2e-46c7-4e1a-b72d-26c0a0b20644",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Oral, small molecule, tyrosine kinase inhibitor (TKI) selective for VEGFRs 1, 2, and 3.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Sunitinib",
        "type": {
          "id": "201cf8af-0fb8-4c5a-816f-9fcafbdfc52b",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "bc450664-54cc-4067-b214-2fdf0fcea218",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Oral, multitargeted TKI of KIT, PDGFRs, VEGFRs, RET, and FLT3; used as monotherapy in the control arm.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Anti-emetic treatment",
        "type": {
          "id": "3c0d4979-af95-49b7-a04f-ec287ccedc7d",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "9c624f21-ae64-4752-aabf-23fcddc88b6b",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted supportive care for prophylaxis or treatment of nausea/vomiting.",
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Hematopoietic Growth Factors",
        "type": {
          "id": "5f6f7cb2-d213-41cb-ab4d-22c64e331bc7",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "20d55b42-41c0-40f7-87b0-602020ef2001",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Mentioned under concomitant treatments section.",
        "administrationIds": [
          "admin_5"
        ]
      },
      {
        "id": "int_6",
        "name": "CYP3A4/5 Inhibitors and Inducers",
        "type": {
          "id": "604f00b3-1099-4619-8f70-860c6227a9e0",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0f090ef4-3897-4b9b-aa42-295669d70e1a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Medications that may interact with axitinib or sunitinib metabolism."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Avelumab (MSB0010718C)",
        "administrableDoseForm": {
          "id": "b2f2d2f7-eedc-4457-9531-44b05c8ed291",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "052852db-1d28-48a9-9d75-9b278ea5e4cf",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "d8d8739c-0dad-4e7a-9deb-441dfece343e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Pfizer and Merck KGaA/EMD Serono"
      },
      {
        "id": "prod_2",
        "name": "Axitinib (INLYTA速)",
        "administrableDoseForm": {
          "id": "992b4e10-cd5b-4b77-b6dc-b1ae426bbdb3",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "528b09d3-4a35-44b3-9b48-86f662bd6824",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "331d7401-0f8b-44cf-b449-bc1c009cb39b",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified in provided text",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Pfizer"
      },
      {
        "id": "prod_3",
        "name": "Sunitinib Malate (SUTENT速)",
        "administrableDoseForm": {
          "id": "2e62fc26-66cb-41f8-b715-5631ed951f74",
          "code": "C25158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Capsule",
          "standardCode": {
            "id": "f1671288-ca66-42f6-83e5-45d3bfbe3ebd",
            "code": "C25158",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Capsule",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "5f3ce498-4355-4893-a90b-0cb27773cfff",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "50 mg",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Pfizer"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Arm A: Avelumab regimen",
        "instanceType": "Administration",
        "dose": "10 mg/kg",
        "doseFrequency": "every 2 weeks",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression, unacceptable toxicity, or withdrawal"
      },
      {
        "id": "admin_2",
        "name": "Arm A: Axitinib regimen",
        "instanceType": "Administration",
        "dose": "5 mg",
        "doseFrequency": "twice daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Continuous"
      },
      {
        "id": "admin_3",
        "name": "Arm B: Sunitinib regimen",
        "instanceType": "Administration",
        "dose": "50 mg",
        "doseFrequency": "once daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "4 weeks on, 2 weeks off (Schedule 4/2) in 6-week cycles"
      },
      {
        "id": "admin_4",
        "name": "Axitinib Dose Level -1",
        "instanceType": "Administration",
        "dose": "3 mg",
        "doseFrequency": "twice daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Dose reduction for toxicity"
      },
      {
        "id": "admin_5",
        "name": "Axitinib Dose Level -2",
        "instanceType": "Administration",
        "dose": "2 mg",
        "doseFrequency": "twice daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Dose reduction for toxicity"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Avelumab",
        "instanceType": "Substance",
        "description": "Anti-PD-L1 monoclonal antibody"
      },
      {
        "id": "sub_2",
        "name": "Axitinib",
        "instanceType": "Substance",
        "description": "VEGFR tyrosine kinase inhibitor"
      },
      {
        "id": "sub_3",
        "name": "Sunitinib Malate",
        "instanceType": "Substance",
        "description": "Multitargeted tyrosine kinase inhibitor"
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Home Blood Pressure Monitoring Device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      }
    ],
    "summary": {
      "interventionCount": 6,
      "productCount": 3,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Avelumab",
        "role": "Investigational Product",
        "description": "Fully human monoclonal antibody (mAb) of the immunoglobulin (Ig) G1 isotype that selectively binds to PD-L1."
      },
      {
        "name": "Axitinib",
        "role": "Investigational Product",
        "description": "Oral, small molecule, tyrosine kinase inhibitor (TKI) selective for VEGFRs 1, 2, and 3."
      },
      {
        "name": "Sunitinib",
        "role": "Comparator",
        "description": "Oral, multitargeted TKI of KIT, PDGFRs, VEGFRs, RET, and FLT3; used as monotherapy in the control arm."
      },
      {
        "name": "Anti-emetic treatment",
        "role": "Concomitant Medication",
        "description": "Permitted supportive care for prophylaxis or treatment of nausea/vomiting."
      },
      {
        "name": "Hematopoietic Growth Factors",
        "role": "Concomitant Medication",
        "description": "Mentioned under concomitant treatments section."
      },
      {
        "name": "CYP3A4/5 Inhibitors and Inducers",
        "role": "Concomitant Medication",
        "description": "Medications that may interact with axitinib or sunitinib metabolism."
      }
    ],
    "products": [
      {
        "name": "Avelumab (MSB0010718C)",
        "doseForm": "Solution",
        "strength": "Not specified in provided text",
        "manufacturer": "Pfizer and Merck KGaA/EMD Serono"
      },
      {
        "name": "Axitinib (INLYTA速)",
        "doseForm": "Tablet",
        "strength": "Not specified in provided text",
        "manufacturer": "Pfizer"
      },
      {
        "name": "Sunitinib Malate (SUTENT速)",
        "doseForm": "Capsule",
        "strength": "50 mg",
        "manufacturer": "Pfizer"
      }
    ],
    "substances": [
      {
        "name": "Avelumab",
        "description": "Anti-PD-L1 monoclonal antibody"
      },
      {
        "name": "Axitinib",
        "description": "VEGFR tyrosine kinase inhibitor"
      },
      {
        "name": "Sunitinib Malate",
        "description": "Multitargeted tyrosine kinase inhibitor"
      }
    ],
    "administrations": [
      {
        "name": "Arm A: Avelumab regimen",
        "dose": "10 mg/kg",
        "frequency": "every 2 weeks",
        "route": "Intravenous",
        "duration": "Until disease progression, unacceptable toxicity, or withdrawal"
      },
      {
        "name": "Arm A: Axitinib regimen",
        "dose": "5 mg",
        "frequency": "twice daily",
        "route": "Oral",
        "duration": "Continuous"
      },
      {
        "name": "Arm B: Sunitinib regimen",
        "dose": "50 mg",
        "frequency": "once daily",
        "route": "Oral",
        "duration": "4 weeks on, 2 weeks off (Schedule 4/2) in 6-week cycles"
      },
      {
        "name": "Axitinib Dose Level -1",
        "dose": "3 mg",
        "frequency": "twice daily",
        "route": "Oral",
        "duration": "Dose reduction for toxicity"
      },
      {
        "name": "Axitinib Dose Level -2",
        "dose": "2 mg",
        "frequency": "twice daily",
        "route": "Oral",
        "duration": "Dose reduction for toxicity"
      }
    ],
    "devices": [
      {
        "name": "Home Blood Pressure Monitoring Device",
        "manufacturer": "Not specified",
        "purpose": "Daily monitoring of blood pressure by patients at home"
      }
    ]
  }
}